iqvia semaglutide tirzepatide prescriptions us q3 2024 The drug that works. But only if you never stop taking it. Swipe to find out why that matters 👉🏽 #familyfinance #glp #ozempic New weight-loss drugs set to

Understanding the role of GLP-1 agonists in NAFLD management is increasingly relevant given the condition's high prevalence and limited pharmacological treatment options

The goal is an improved metabolic profile: reduced risk or reversal of type 2 diabetes, reduction in fatty liver disease, reduction in cardiovascular disease, and reduced risk of other co-morbidities of obesity including certain cancers

These peptide hormones were developed initially as a type 2 diabetes treatment that works with the pancreas to enhance insulin release in response to meals

As a result, patients must be 18 years or older and: Have type 2 diabetes and a BMI of 30 or more Have type 2 diabetes and a BMI of 27 with one or more weight-related health conditions

It also presents an opportunity to increase potassium excretion with potassium binders that pass right through the GI system [16]